Dr. Bhaswat Chakraborty

President/CEO/Company Owner
Cadila Pharmaceuticals Limited, India

Highest Degree
Ph.D. in Clinical Pharmacology from University of Saskatchewan, Canada

My URL
https://livedna.org/91.2106

Share this Profile

Area of Interest:

Pharmacology and Toxicology
Clinical Pharmacology
Bianalytical Method Development
Biequivalence Trials
Pharmacy

Selected Publications

  1. Raja, C., N, Sagar, and C. Bhaswat, 2014. Recent insights into the association of chronic inflammatory andneurodegenerative processes in clinical depression. J. Funda. Pharma. Res, 2: 57-61.
    Direct Link  |  

  2. Chakraborty B.S., 2014. Pharmacovigilance: curriculum and career. J. Adv. Pharm. Technol. Res, 5: 2-3.
    CrossRef  |  PubMed  |  Direct Link  |  

  3. Sakore, S., and B. Chakraborty, 2013. Formulation and evaluation of enalapril maleate sustained release matrix tablets. Int. J. Pharm. Biomed. Res, 4: 21-26.
    Direct Link  |  

  4. Chakraborty, B.S., 2013. Critical issues in the conduct of antihypertensive clinical trials. J. Pharma. Sci. Tech, 2: 47-55.
    Direct Link  |  

  5. Chakraborty, B.S., 2013. Clinical research in india: the current scenario and prospects. J. Adv. Pharm. Technol. Res, 4: 126-127.
    CrossRef  |  PubMed  |  Direct Link  |  

  6. Sakore, S., and B. Chakraborthy, 2012. IN-VITRO and in-vivo correlation of immediate release acyclovir tablet using wagner nelson method. Int. J. Phaema, 2: 598-604.
    Direct Link  |  

  7. Ghosh, C., and B. Chakraborty, 2012. LC-MS Methods for Regulated Bioequivalence Studies: Do We Need to Worry about Matrix Effects? Omics Online Scientific Reports. Omics. Online. Sci. Rep, 1: 424-429.
    Direct Link  |  

  8. Ghosh, C., V. Jha, C. Patra, R. Ahir and B. Chakraborty, 2012. SIMULTANEOUS determination of docosahexaenoic acid and eicosapentaenoic acid by lc-esi-ms/ms from human plasma. J. Liq. Chromatogr. Related Technol, 35: 1812-1825.
    Direct Link  |  

  9. Ghosh, C., I. Jain, C.P. Shinde and B.S. Chakraborty, 2012. Rapid and sensitive liquid chromatography/tandem mass spectrometry method for simultaneous determination of enalapril and its major metabolite enalaprilat, in human plasma: Application to a bioequivalence study. Drug Test. Anal., 4: 94-103.
    CrossRef  |  PubMed  |  Direct Link  |  

  10. Ghosh, C., C.P. Shinde, and B. Chakraborty, 2012. Influence of ionization source design on matrix effects during lc-esi-ms/ms analysis. J. Chromatogr. B, 893: 193-200.
    CrossRef  |  PubMed  |  Direct Link  |  

  11. Kumar, A., R. Kachhadiya amd B.S. Chakraborty, 2011. Clinical outcome of patients of acute coronary syndrome at 7 and 30 days undergoing percutaneous coronary interventions and treated with bivalirudin and heparin. Int. J. Contemp. Res. Rev., 2: 31-35.

  12. Ghosh, C., and S. Gaur, C.P. Shinde, and B. Chakraborty, 2011. A systematic approach to overcome the matrix effect during lc-esi-ms/ms analysis by different sample extraction techniques. J. Bioequivalence Bioavailability, 3: 122-127.
    Direct Link  |  

  13. Ghosh, C., V. Jha, C.P. Shinde and B.S. Chakraborty, 2011. A LC-MS analysis of acamprosate from human plasma: pharmacokinetic application. Drug Test. Anal., 3: 735-742.
    CrossRef  |  PubMed  |  Direct Link  |  

  14. Ghosh, C., S. Gaur, A. Singh, C.P. Shinde and B.S. Chakraborty, 2011. Estimation of nevirapine from human plasma by ESI-LC-MS/MS: A pharmacokinetic application. J. Bioequivalence Bioavailability, 3: 20-25.
    CrossRef  |  Direct Link  |  

  15. Ghosh, C., I. Jain, S. Gaur, N. Patel, A. Upadhyay and B.S. Chakraborty, 2011. Simultaneous estimation of atorvastatin and its two metabolites from human plasma by ESI-LC-MS/MS. Drug Test. Anal., 3: 352-362.
    CrossRef  |  PubMed  |  Direct Link  |  

  16. Ghosh, C., A. Upadhayay, A. Singh, S. Bahadur, and B. S. Chakraborty,et al, 2011. SIMULTANEOUS determination of aspirin and its metabolite from human plasma by uplc-uv detection: application to pharmacokinetic study. J. Liq. Chromatogr. Related Technol, 34: 2326-2338.
    CrossRef  |  Direct Link  |  

  17. Chakraborty, B.S., 2011. Clinical trials of antihypertensives: Nature of control and design. Indian J. Pharmacol., 43: 13-17.
    CrossRef  |  PubMed  |  Direct Link  |  

  18. Sharma, G.N., B.S. Chakraborty, J. Sanadya, U.S. Baghel, C. Ghosh and M. Singhal, 2010. Bio-analytical estimation of losartan and losartan carboxylic acid concentrations in human plasma by using LC-MS/MS. Int. J. Pharm. Qual. Assur., 2: 13-18.
    Direct Link  |  

  19. Sakore, S., S. Kute, A. Tekade and B.S. Chakraborty, 2010. Long acting in situ gelling vehicle for ophthalmic delivery: A research. Int. J. Drug Formulation Res., 1: 324-348.

  20. Sakore, S., S. Chaudhary and B.S. Chakraborty, 2010. Biowaiver monograph for immediate release solid oral dosage forms: Ofloxacin. Int. J. Pharm. Pharm. Sci., 2: 156-161.
    Direct Link  |  

  21. Patel, C.D., V.D. Modi, B.S. Chakraborty, N. Mathuria, P. Dadhaniya, P.A. Borade and P. Morankar, 2010. Effect of a novel antiinflammatory polyherbal preparation (Sudarshanam oil) on hematological parameters in Wistar rats. Acta Poloinae Pharm. Drug Res., 67: 277-281.
    PubMed  |  

  22. Patel, A., T. Shah, G. Shah, V. Jha and C. Ghosh et al., 2010. Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (Polycap ™). Am. J. Cardiovasc. Drugs, 10: 95-103.
    CrossRef  |  PubMed  |  Direct Link  |  

  23. Kute, S.D., S. Sakore and B.S. Chakraborty, 2010. Formulation approaches in ocular drug delivery system. Int. J. Pharm. Sci. Technol., 2: 118-145.
    Direct Link  |  

  24. Kumar, A., R.K. Kachhadiya, V. Vaishnavi and B.S. Chakraborty, 2010. Comparison of tumor response rate and toxicities with polychemotherapy versus monochemotherapy in patients of metastatic breast cancer: A meta-analysis. Int. J. Curr. Res. Rev., 1: 1-9.

  25. Ghosh, C., V. Jha, R. Ahir, S. Shah, C.P. Shinde and B.S. Chakraborty, 2010. A rapid and most sensitive liquid chromatography/tandem mass spectrometry method for simultaneous determination of alverine and its major metabolite, para hydroxy alverine, in human plasma: Application to a pharmacokinetic and bioequivalence study. Drug Test. Anal., 2: 284-291.
    CrossRef  |  PubMed  |  Direct Link  |  

  26. Ghosh, C., C.P. Shinde and B.S. Chakraborty, 2010. Ionization polarity as a cause of matrix effects, its removal and estimation in ESI-LC-MS/MS bio-analysis. J. Anal. Bioanal. Tech., 1: 106-106.
    CrossRef  |  Direct Link  |  

  27. Jain, S., V.V. Vaishnavi and B.S. Chakraborty, 2009. The effect of dyslipidemic drugs on mortality: A meta-analysis. Indian J. Pharmacol., 41: 4-8.
    CrossRef  |  PubMed  |  Direct Link  |  

  28. Ghosh, C., R.P. Singh, S. Inamdar, M. Mote and B.S. Chakraborty, 2009. Sensitive, selective, precise and accurate LC-MS method for determination of clonidine in human plasma. Chromatographia, 69: 1227-1232.
    CrossRef  |  Direct Link  |  

  29. Gavali, D., K.S. Kulkarni, A. Kumar and B.S. Chakraborty, 2009. Therapeutic class specific signal detection of bradycardia associated with propranolol hydrochloride. Ind. J. Pharmacol., 41: 162-166.
    CrossRef  |  PubMed  |  Direct Link  |  

  30. Verma, R.J., B.S. Chakraborty, C. Patel and N. Mathuria, 2008. Curcumin ameliorates aflatoxin-induced changes in SDH and ATPase activities in liver and kidney of mice. Acta Poloinae Pharm. Drug Res., 65: 415-419.
    PubMed  |  

  31. Dadhaniya, P., C. Patel, M. Makwana, K. Vachhani, B.K. Gunale, A. Maseeh and B. Chakraborty, 2008. Safety assessment of tenatoprazole. Acute and subacute toxicity studies. Indian J. Clin. Pract., 19: 23-27.

  32. Pant, M.C., B.S. Chakraborty, N. Patel, S.S. Bisht and V.P. Verma et al., 2007. Role of Cadi-05 as an adjuvant therapy in advanced non small cell lung cancer: P3-022. J. Thoracic Oncol., 2: S616-S616.
    CrossRef  |  Direct Link  |  

  33. Chakraborty, B.S., 2007. Cancer drug development-key regulatory considerations. Health Admin., 20: 29-36.
    Direct Link  |  

  34. Gallicano, K.D., I.J. McGilveray, S. Qureshi, W. Nitchuk, and B. Chakraborty,et al, 1991. Comparative bioavailability of oral contraceptive products. Clin. Biochem, 24: 107-111.
    CrossRef  |  Direct Link  |  

  35. Midha, K. K., B. S. Chakraborty, R. Schwede, E. M. Hawes, and G. McKay,et al, 1990. Comparative bioavailability of two tablet formulations of fluphenazine dihydrochloride in drug-free psychiatric patients. J. Pharm. Sci, 79: 3-8.
    CrossRef  |  PubMed  |  Direct Link  |  

  36. Midha KK1, G. McKay, B.S. Chakraborty, M.Young, and E.M.Hawes,et al, 1990. Bioequivalence of two thorazine tablet formulations using radioimmunoassay and gas chromatographic-mass spectrometric methods. J. Pharm. Sci, 79: 196-201.
    PubMed  |  

  37. Midha, K.K., B.S. Chakraborty, D.A. Ganes, M.M. Hawes, and J.W. Hubbard,et al, 1989. Intersubject variation in the pharmacokinetics of haloperidol and reduced haloperidol. J. Clin. Psychopharmacol, 9: 98-104.
    PubMed  |  

  38. Midha, K. K., B. S. Chakraborty, E. M. Hawes, J. W. Hubbard, and G. McKay,et al,, 1989. Comparative bioavailability of a new commercial tablet formulation and two lots of a reference formulation of haloperidol. J.Pharm.Sci, 78: 443-447.
    CrossRef  |  PubMed  |  Direct Link  |  

  39. Chakraborty, B.S., J. W. Hubbard, E. M. Hawes, G. McKay, and J. K. Cooper,et al, 1989. Interconversion between haloperidol and reduced haloperidol in healthy volunteers. Eur. J. Clin. Pharmacol, 37: 45-48.
    CrossRef  |  PubMed  |  Direct Link  |  

  40. Chakraborty, B. S., K. K. Midha, G. McKay, E. M. Hawes, and J. W. Hubbard,et al, 1989. Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: A dose proportionality study. J. Pharm. Sci, 78: 769-801.
    CrossRef  |  PubMed  |  Direct Link  |  

  41. Chakraborty, B.S., E.M. Hawes, G. McKay, J.W. Hubbard, and E.D. Korchinski,et al, 1988. S-OXIDATION of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteers. Drug. Metabol. Drug. Interact, 6: 425-438.
    CrossRef  |  PubMed  |  Direct Link  |  

  42. Chakraborty B.S., E.M. Hawes and K.K. Midha, 1988. Development of a radioimmunoassay procedure for sulforidazine and its comparison with a high-performance liquid chromatographic method. Ther. Drug. Monit, 10: 205-214.
    PubMed  |  

  43. Chakraborty, B.S., M. S. Sardessai, T. J. Jaworski, K. K. Midha and E. M. Hawes,et al., 1987. Synthesis and properties of haptens for the development of radioimmunoassays for thioridazine, mesoridazine, and sulforidazine. Pharma. Res, 4: 207-213.
    CrossRef  |  Direct Link  |  

  44. Chakraborty, B.S., E.M. Hawes and K.K. Midha, 1987. Development of a radioimmunoassay procedure for mesoridazine and its comparison with a high-performance liquid chromatographic method. Ther. Drug. Monit, 9: 464-471.
    PubMed  |  
Member since June, 2010